Authors


David Hui, MD, MSc

Latest:

Many Patients Are Under-Sedated During End-of-Life Cancer Care

David Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses findings indicating that patients with agitated delirium may be under-sedated, in accordance with their personalized sedation goal.


Karyn A. Goodman, MD, MS

Latest:

Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer

Karyn A. Goodman, MD, MS, provides perspective on the potential advantages of stereotactic body radiation therapy in locally advanced pancreatic cancer.


John Lewandowski, PA-C, MS

Latest:

A Multidisciplinary Approach Improves a Patient’s Experience With Colon Cancer

Early coordination with multiple specialty teams can maximize outcomes and improve quality of life for patients with complex metastatic disease.


Estelamari Rodriguez, MD

Latest:

How I Counsel Patients About Lung Cancer Screening

A lung cancer screening navigator offers their perspective on shared decision-making.


Roman Fabbricatore

Latest:

Osimertinib Sustains OS Improvement in EGFR-Mutant NSCLC

Osimertinib monotherapy and combination treatment had safety profiles consistent with previous data on use of the drug in EGFR-mutated NSCLC.


Sherry Adkins, MSN, ANP-C

Latest:

Sherry Adkins Talks Primary Care Provider Communication Following CAR T-cell Therapy

Sherry Adkins, MSN, ANP-C, discusses some key considerations in ensuring quality patient care after they have completed CAR T-cell therapy at a specialized center.


Katy Beckermann, MD, PhD

Latest:

Dose Reductions Possible for Tivozanib With and Without Nivolumab for RCC

Katy Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose modifications for patients with RCC.


Matthew Goetz, MD

Latest:

Grace Choong and Matthew Goetz On the Impact of Adjuvant Endocrine Therapy Omission in ER+ Positive Breast Cancer

Grace Choong, MD; and Matthew Goetz, MD, discuss the effect of omitting adjuvant endocrine therapy for patients with estrogen receptor–positive breast cancer who were treated with neoadjuvant chemotherapy.


Ashley B. Johnson, MSN, APRN, FNP-C

Latest:

Considerations for Premenopausal Women With TNBC

Triple-negative breast cancer often occurs in women younger than 40.


Sarah Low, RN, MSN, OCN, CMSRN

Latest:

Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient Ambulation

Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.


Binod Dhakal, MD

Latest:

Life After CAR T Therapy: Insights for Patients and Referring Oncologists

This video segment focuses on key elements of patient education and support for long-term CAR-T survivors, strategies to maintain quality of life and manage late effects, differences in supportive care needs between ide-cel and cilta-cel recipients, and approaches to fostering collaboration between academic centers and community practices for optimal long-term care.


Brianna Lutz, MSN, RN, OCN

Latest:

Brianna Lutz on How to Improve Nurse Responsiveness on an Inpatient Oncology Unit

Brianna Lutz, MSN, RN, OCN, discusses a red-and-green dot hourly column that shows which patients with cancer have been attended to in the past hour.


Kelley A. Rone, DNP, RN, AGNP-c

Latest:

Kelley Rone on the Evolving Role of Immunotherapy in GI Cancers

Kelley A. Rone, DNP, RN, AGNP-c, discusses the advantages associated with immunotherapy in the treatment of patients with gastrointestinal cancers.


Courtney Flaherty

Latest:

Nemvaleukin Lacks OS Benefit Over Chemo in Platinum-Resistant Ovarian Cancer

Evaluation of nemvaleukin for platinum-resistant ovarian cancer will be terminated based on OS data from an interim analysis of the phase 3 ARTISTRY-7 trial.


University of Arizona Cancer Center

Latest:

Cancer Center gets $1.1M gift for holistic cancer care

The gift is from the estate of Tom and Catherine Culley, longtime residents of the East Coast and worldwide travelers.


Jennifer LaPietra, LMSW

Latest:

Reducing Health Inequities Among BIPOC Patients With Melanoma

One expert wrote that through education, prevention, and support, oncology nurses may play a role in reducing health inequities in melanoma.


Sumanta Pal, MD, FASCO

Latest:

Sequencing Strategies in RCC: Optimizing Treatment Selection After IO-Based Therapy

Experts discuss sequencing strategies in renal cell carcinoma (RCC), focusing on optimizing treatment selection after immune-oncology (IO)–based therapy.


Medically reviewed by: Stacey Abels, PhD

Latest:

Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)

Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.


Charles E. Geyer, MD, FACP

Latest:

Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast Cancer

Charles E. Geyer, MD, FACP, discusses dosing strategies and adverse event management with olaparib.


Nilam Patel, PA-C

Latest:

Evolving Treatment Strategies in Early HER2+ Breast Cancer

Experts discuss how, nearly half of patients diagnoses with HER-2 positive metastatic brain cancer do develop brain metastasis. It is thought that larger molecule treatments such as the monoclonal antibodies likely do not cross an intact blood brain barrier which is often why patients develop brain metastases


Melisa Celikoyar, LCSW

Latest:

Opinion: Wilderness Therapy Offers Benefits to Patients With Cancer

Wilderness therapy is a nontraditional form of therapy that uses components of exposure to outdoor activity and mental health treatment.


Hashim Mann, MD

Latest:

Referral Process With Bispecifics: Challenges and Support

Dr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.


Kimberly A. Spickes, CNP

Latest:

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.


Janelle Wagner, RN, OCN

Latest:

Setting Boundaries Can Be a Challenge for Nurse Navigators

Janelle Wagner, RN, OCN, Senior Manager of Patient Navigation Program for Community Sites, highlights some challenges commonly associated with nurse navigation, and how nurses can overcome them.


Kate Sandstrom, MSN, APRN-BC, AOCN

Latest:

Kate Sandstrom on Ensuring Patient Follow-Up With Radiation Oncology Teams

Kate Sandstrom, MSN, APRN-BC, AOCN, discusses the importance of including the radiation oncology team in a patient’s long-term care plan.


Patrick Buxton, RN, BSN

Latest:

‘The First Role of the Nurse Is Being an Advocate,’ MPN Specialist Says

Nurses treating patients with MPNs should remember to advocate for and empower them.


Karen Hande, PhD, DNP, APRN, ANP-BC, CNE , FAANP, ANEF

Latest:

Recognition of the Advanced Practice Preceptor Role in Oncology

A tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.


Jorge E. Cortes, MD

Latest:

Advancing CML Management Towards an Ideal Patient Journey

The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.


Joanna Fawzy Doran, Esq.

Latest:

Discussing Lymphedema Treatment Act, Coverage With Patients

Patients insured by Medicare can now receive coverage for lymphedema compression garments as a result of the Lymphedema Treatment Act, but it is essential that oncology nurses communicate this with their patients.


Jeffrey Bendix

Latest:

CMS Predicts Health Care Spending Will Top $7 Trillion by 2031

It is anticipated that health care spending will grow by an annual average of 5.4% over the next 8 years.